You are here

  • Home
  • Archive
  • Volume 10, Issue Suppl 2
  • 1363 Evaluation of the anti-tumor activity of ICVB-1042, a novel E2F-tumor selective oncolytic virus, selectively targeting tumor cells in an established human glioblastoma mouse model

Article metrics

Article menu

Download PDFPDF

Regular and Young Investigator Award Abstracts
Novel Single-Agent Immunotherapies
1363 Evaluation of the anti-tumor activity of ICVB-1042, a novel E2F-tumor selective oncolytic virus, selectively targeting tumor cells in an established human glioblastoma mouse model
Free

 

Online download statistics by month:

Online download statistics by month: November 2022 to September 2024

AbstractFullPdf
Nov 2022290051
Dec 202268013
Jan 202358015
Feb 202372011
Mar 20235408
Apr 202394013
May 202330014
Jun 20232803
Jul 20233605
Aug 20232006
Sep 20234607
Oct 20231803
Nov 20234604
Dec 20235806
Jan 20244403
Feb 20242801
Mar 20242400
Apr 20242603
May 20243006
Jun 20241406
Jul 20241401
Aug 20241805
Sep 20241605
Total11320189